Skip to main content

Does Lantus cause weight gain?

Medically reviewed by Melisa Puckey, BPharm. Last updated on June 14, 2024.

Official answer

by drugclasses.com

Can Lantus cause weight gain?

  • Yes, weight gain is listed as a side effect for Lantus (insulin glargine) insulin

In the clinical trial for Lantus called ORIGIN (The Outcome Reduction with Initial Glargine Intervention trial) they studied patients for a median time of 6.2 years. There were 6264 patients in the Lantus treatment group and 6273 in the standard care treatment group.

The mean weight gain was 2.2 kg greater in the Lantus treatment group compared to the standard care treatment group, over the 6.2 year time period.

Why does insulin often lead to weight gain?

Before diabetes is treated or when diabetes is not being treated effectively you may be passing a lot of glucose out in your urine. This means some of the calories that you are eating are not being absorbed and are being passed out of your body. Also when your diabetes is not treated or not well treated you have an increased urine volume which may mean that you are often dehydrated.

Once your diabetes is being treated efficiently your body is able to hold onto any glucose that your body doesn’t need by storing it, which can be a cause of weight gain. Also when your diabetes is well controlled, you should be well hydrated which increases your weight.

How do I stop weight gain on insulin?

To help reduce the chances of weight gain when on Lantus it is important to discuss with your health care profession about how to change your diet so that you are only taking in the number of calories your body needs for the day. That way your body shouldn’t have any excess calories to store away, which would cause weight gain. Also discuss with your health care professional how you can incorporate more activity and exercise into your lifestyle.

References

Lantus Prescribing information www.drugclasses.com/pro/lantus-solostar.html

Read next

Basaglar and Lantus - What is the difference between them?

Basaglar and Lantus both injections that contain insulin glargine, a long-acting form of insulin to help control blood sugar levels in type 1 and type 2 diabetes. Basaglar is considered a "follow-on" to Lantus but is not a biosimilar, according to the FDA. This means your doctor will need to write a prescription for one or the other as they cannot be substituted at the pharmacy. Continue reading

What are biosimilar drugs and how do they compare to biologics?

A biosimilar is a biological product that is similar to a reference biologic (usually the originally approved product) and for which there are no clinically meaningful differences in terms of safety, purity, and potency. One example is Amjevita (adalimumab-atto), the first biosimilar approved for Humira (adalimumab) on September 23, 2016. Continue reading

Toujeo vs Lantus - What's the difference between them?

Both Toujeo and Lantus are long-acting insulins that contain glargine, however Toujeo is more concentrated containing 300 units per mL of glargine, compared to Lantus’s 100 units per mL. When you take this into account the cost of Toujeo and Lantus works out approximately the same (real cost value $30.76/mL for Toujeo compared with $30.23/mL for Lantus). Continue reading

Related medical questions

Drug information

Related support groups